Loading...
XSHE300326
Market cap659mUSD
Jan 10, Last price  
6.83CNY
1D
-4.34%
1Q
37.42%
Jan 2017
-38.58%
IPO
59.47%
Name

Shanghai Kinetic Medical Co Ltd

Chart & Performance

D1W1MN
XSHE:300326 chart
P/E
43.00
P/S
5.06
EPS
0.16
Div Yield, %
0.11%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
0.54%
Revenues
956m
-17.99%
23,311,44838,771,40758,693,23480,713,570101,692,192126,682,069222,355,564462,885,218550,596,649802,266,759930,906,8101,222,288,0411,061,574,3801,268,579,5101,166,042,082956,259,537
Net income
113m
13,593,59617,914,09835,602,69037,133,33255,523,76964,050,05962,230,255120,648,081158,840,872194,981,405462,567,219302,327,3760161,775,9760112,537,303
CFO
274m
+15.84%
018,391,48131,664,49737,834,50151,515,60433,067,41171,462,771111,157,486130,351,711146,934,35095,252,512255,608,624284,922,007378,155,561236,756,963274,260,691
Dividend
Jul 16, 20240.06 CNY/sh
Earnings
May 22, 2025

Profile

Shanghai Kinetic Medical Co., Ltd manufactures and sells medical devices in China and internationally. It provides products for multidisciplinary specialties, including orthopedics, cardiovascular, and sports medicine. The company offers primom spinal fixation system, a system of instruments and implants designed to treat modern deformity, degenerative, and trauma applications; kyphoplasty systems; vertebral osteotome for cavity creation or working pathway establishment in vertebral body; bone cement delivery systems for distance bone cement delivery; injection guns for bone cement injection; and multifunctional tools for insertion and working pathway set-up. It also provides kinect locking compression plate systems. The company was founded in 2005 and is based in Shanghai, China.
URL
http://www.kineticmedinc.com.cn/
IPO date
Jun 13, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
956,260
-17.99%
1,166,042
-8.08%
Cost of revenue
699,399
802,849
Unusual Expense (Income)
NOPBT
256,861
363,193
NOPBT Margin
26.86%
31.15%
Operating Taxes
6,979
21,689
Tax Rate
2.72%
5.97%
NOPAT
249,882
341,504
Net income
112,537
 
Dividends
(5,110)
(35,539)
Dividend yield
0.11%
0.69%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
119,068
286,022
Long-term debt
107,348
70,182
Deferred revenue
6,538
8,272
Other long-term liabilities
600
600
Net debt
(1,334,375)
(819,177)
Cash flow
Cash from operating activities
274,261
236,757
CAPEX
(53,789)
Cash from investing activities
(186,669)
Cash from financing activities
(174,915)
FCF
364,755
354,813
Balance
Cash
1,041,667
971,892
Long term investments
519,124
203,489
Excess cash
1,512,978
1,117,079
Stockholders' equity
2,084,680
2,116,389
Invested Capital
1,615,552
2,011,273
ROIC
13.78%
16.68%
ROCE
8.17%
11.58%
EV
Common stock shares outstanding
716,798
719,003
Price
6.33
-12.08%
7.20
-32.46%
Market cap
4,537,332
-12.35%
5,176,823
-32.73%
EV
3,291,764
4,432,778
EBITDA
334,852
625,152
EV/EBITDA
9.83
7.09
Interest
6,564
14,118
Interest/NOPBT
2.56%
3.89%